BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall Street falls as oil rebounds, Middle East tensions simmer
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil up almost 2% as Iran's president vows to never surrender
- On Holding sets 2029 financial targets, authorizes $1B share buyback
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Nasdaq reaches record high close, AI stocks rally
- Elmet Group signs tungsten offtake deal with Hemerdon Mine
- Meta bull case increasingly playing out, Mizuho says
Becton Dickinson (BDX) shares hit record high after Alaris Infusion System fully cleared by FDA
July 24, 2023 10:56 AM EDTShares of Becton Dickinson (NYSE: BDX) climbed after its updated Alaris Infusion System received 510(k) clearance from the U.S. Food and Drug Administration, allowing it to return to full commercial operations. Alaris was previously restricted in the U.S. except for under medical necessity, and the change is seen as a positive catalyst for shares.
"Now that we have FDA clearance, we are... More
Becton Dickinson (BDX) Climbs 6.5% Following FDA 510(k) clearance of BD Alaris Infusion System
July 24, 2023 8:35 AM EDTBecton Dickinson (NYSE: BDX) Climbs 6.5% Following FDA 510(k) clearance of BD Alaris Infusion System
... More